These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35527332)
1. LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRI. Jia Y; Wang H; Zhang M; Wei M; Huang Z; Ye J; Liu A; Wang Y Acta Neurol Belg; 2023 Jun; 123(3):849-856. PubMed ID: 35527332 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179 [TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures. Li Z; Cui T; Shi W; Wang Q Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233 [TBL] [Abstract][Full Text] [Related]
4. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Irani SR; Michell AW; Lang B; Pettingill P; Waters P; Johnson MR; Schott JM; Armstrong RJ; S Zagami A; Bleasel A; Somerville ER; Smith SM; Vincent A Ann Neurol; 2011 May; 69(5):892-900. PubMed ID: 21416487 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis. Li Y; Song F; Liu W; Wang Y Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701 [TBL] [Abstract][Full Text] [Related]
6. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis. Huang X; Fan C; Gao L; Li L; Ye J; Shen H J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327 [TBL] [Abstract][Full Text] [Related]
7. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis]. Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994 [TBL] [Abstract][Full Text] [Related]
8. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis. Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866 [TBL] [Abstract][Full Text] [Related]
9. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies. Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970 [TBL] [Abstract][Full Text] [Related]
10. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis. Li LH; Ma CC; Zhang HF; Lian YJ Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune encephalitis related to LGI1 antibodies with negative MRI study: Description of two cases. Lian X; Zheng K; Chen W; Li D; Xue F; Wang G Med Clin (Barc); 2024 Jan; 162(1):35-38. PubMed ID: 37517931 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification. Liang M; Niu N; Jia C; Fan S; Liu L; Cui R; Guan H Clin Nucl Med; 2023 Nov; 48(11):e516-e522. PubMed ID: 37703438 [TBL] [Abstract][Full Text] [Related]
13. Three cases of antibody-LGI1 limbic encephalitis and review of literature. Bing-Lei W; Jia-Hua Z; Yan L; Zan Y; Xin B; Jian-Hua S; Hui-Juan W Int J Neurosci; 2019 Jul; 129(7):642-648. PubMed ID: 30112956 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies. Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017 [TBL] [Abstract][Full Text] [Related]
16. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure. Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863 [TBL] [Abstract][Full Text] [Related]
17. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis. Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068 [TBL] [Abstract][Full Text] [Related]
18. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis. Dürr M; Nissen G; Sühs KW; Schwenkenbecher P; Geis C; Ringelstein M; Hartung HP; Friese MA; Kaufmann M; Malter MP; Madlener M; Thaler FS; Kümpfel T; Senel M; Häusler MG; Schneider H; Bergh FT; Kellinghaus C; Zettl UK; Wandinger KP; Melzer N; Gross CC; Lange P; Dreyhaupt J; Tumani H; Leypoldt F; Lewerenz J; Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34697224 [TBL] [Abstract][Full Text] [Related]
19. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China. Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063 [TBL] [Abstract][Full Text] [Related]
20. Clinical characterization of autoimmune LGI1 antibody limbic encephalitis. Gao L; Liu A; Zhan S; Wang L; Li L; Guan L; Zhao X; Zhang X; Wang Y Epilepsy Behav; 2016 Mar; 56():165-9. PubMed ID: 26896820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]